Deciphera Pharmaceuticals, Inc. (DCPH)
After hours:
| Previous close | 25.27 |
| Open | 25.30 |
| Bid | 25.33 x 200 |
| Ask | 25.39 x 100 |
| Day's range | 25.27 - 25.40 |
| 52-week range | 9.90 - 25.40 |
| Volume | |
| Avg. volume | 1,421,554 |
| Market cap | 2.085B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
WALTHAM, Mass., April 29, 2024--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd. (ONO), under which ONO will acquire all outstanding shares of Deciphera common stock for $25.60 per share in cash through a tender offer followed by a merger of De
- Business Wire
Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
WALTHAM, Mass., April 09, 2024--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management team will participate in a fireside chat at the Stifel 2024 Virtual Targeted Oncology Forum on Tuesday, April 16, 2024 at 11:30 AM ET.
- Business Wire
Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences
WALTHAM, Mass., February 27, 2024--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management team will participate in fireside chats at the following investor conferences:
